Joshua Ziel, Ph.D., Appointed As Chief Executive Officer of Bryn Pharma, Llc

Oct 24, 2024•9 months ago

Position

Chief Executive Officer

Company

Bryn Pharma

Joshua Ziel

RaleighHealthcare

Description

Bryn Pharma, LLC has announced the appointment of Joshua Ziel, Ph.D., as the Chief Executive Officer and member of the Board of Directors. This appointment comes as Sandy Loreaux, former CEO, steps down for family-related reasons but will continue to serve on the Board of Directors to guide company strategy.

Company Information

Company

Bryn Pharma

Location

Raleigh, North Carolina, United States

About

Bryn Pharma is a privately held pharmaceutical company based in North Carolina. Primary focus is on the development and commercialization of innovative allergy products for the management of anaphylaxis. The mission of Bryn Pharma is to empower patients with a life-saving device that is small enough to comfortably fit in your pocket and easy to use in the event of an anaphylactic attack. Our intranasal delivery system will be an exciting alternative to epinephrine auto-injectors providing patients a needle-free option that is easy to use, portable, and affordable.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Joshua hidden